Bivariate and Multivariable Analyses of Patient Characteristics Associated with Receiving Help from the Primary Care Physician Regarding Treatment
| Received Help from the PCP, n (%) | P Value* | Adjusted Model,† Odds Ratio (95% CI) | P Value | ||
|---|---|---|---|---|---|
| No | Yes | ||||
| Total | 1375 (59.9) | 876 (38.2) | |||
| Age (years) | .24 | ||||
| <60 | 340 (24.8) | 220 (25.3) | Reference | ||
| 60–64 | 276 (20.1) | 175 (20.1) | 0.96 (0.72–1.27) | .77 | |
| 65–69 | 363 (26.4) | 200 (23.0) | 0.75 (0.51–1.09) | .13 | |
| 70–74 | 220 (16.0) | 141 (16.2) | 0.78 (0.51–1.19) | .25 | |
| ≥75 | 175 (12.7) | 135 (15.5) | 0.85 (0.55–1.35) | .50 | |
| Race/ethnicity | <.001 | ||||
| Non-Hispanic white | 1144 (85.1) | 637 (75.3) | Reference | ||
| Non-Hispanic black | 167 (12.4) | 177 (20.9) | 1.76 (1.37–2.27) | <.001 | |
| Hispanic | 20 (1.5) | 20 (2.4) | 1.72 (0.91–3.28) | .10 | |
| Non-Hispanic other | 13 (1.0) | 12 (1.4) | 1.48 (0.68–3.22) | .33 | |
| Education | .04 | ||||
| Less than high school | 75 (5.9) | 73 (9.1) | Reference | ||
| High school graduate | 316 (24.8) | 205 (25.6) | 0.86 (0.61–1.26) | .48 | |
| Some college | 275 (21.6) | 179 (22.3) | 0.92 (0.63–1.36) | .69 | |
| College graduate | 214 (16.8) | 127 (15.8) | 0.97 (0.64–1.46) | .87 | |
| More than college | 396 (31.0) | 218 (27.2) | 0.91 (0.62–1.32) | .62 | |
| Insurance | .28 | ||||
| Private | 783 (57.5) | 469 (54.3) | Reference | ||
| Medicaid | 34 (2.5) | 31 (3.6) | 0.87 (0.50–1.50) | .61 | |
| Medicare | 539 (39.6) | 361 (41.8) | 1.04 (0.82–1.33) | .74 | |
| None | 6 (0.4) | 3 (0.4) | 0.66 (0.16–2.70) | .56 | |
| Employment | <.001 | ||||
| Unemployed/other | 117 (9.2) | 116 (14.5) | Reference | ||
| Employed | 579 (45.3) | 309 (38.6) | 0.75 (0.54–1.04) | .09 | |
| Retired | 581 (45.5) | 376 (46.9) | 0.83 (0.59–1.14) | .24 | |
| Marital Status | .08 | ||||
| Single | 241 (17.7) | 179 (20.7) | Reference | ||
| Married | 1122 (82.3) | 688 (79.4) | 1.03 (0.81–1.30) | .84 | |
| 10-Year mortality risk | <.001 | ||||
| <25% | 395 (30.3) | 221 (27.3) | Reference | ||
| 25–50% | 486 (37.2) | 250 (30.9) | 1.10 (0.79–1.54) | .54 | |
| 50–75% | 299 (22.9) | 244 (30.1) | 1.62 (1.11–2.36) | .01 | |
| ≥75% | 125 (9.6) | 95 (11.7) | 1.36 (0.87–2.13) | .18 | |
| Gleason score | .73 | ||||
| ≤6 | 554 (41.3) | 336 (39.6) | Reference | ||
| 7 | 549 (40.9) | 359 (42.3) | 1.03 (0.84–1.25) | .77 | |
| >7 | 238 (17.8) | 153 (18.0) | 1.03 (0.80–1.34) | .80 | |
| Clinical tumor stage | .92 | ||||
| 1 | 984 (72.8) | 627 (73.0) | Reference | ||
| 2 | 335 (24.8) | 214 (24.9) | 0.99 (0.80–1.22) | .93 | |
| 3 | 32 (2.4) | 18 (2.1) | 0.88 (0.48–1.62) | .68 | |